Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid and Low-dose Dexamethasone in Japanese Patients With Previously Untreated Multiple Myeloma
NCT01698801Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Oct 2012
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Oct 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01698801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698801.